Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis.
The risk of Bipolar Disorders in Multiple Sclerosis.
Editorial for JNV issue on PML.
Azathioprine versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis: A Multicentre Randomized Non-Inferiority Trial.
Association mapping of disease loci, by use of a pooled DNA genomic screen.
Platelets provide a bounty of potential targets for therapy in multiple sclerosis.
Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in sweden.
Recent Gains in Clinical Multiple Sclerosis Research Review.
Interpretation and visualization of non-linear data fusion in kernel space: study on metabolomic characterization of progression of multiple sclerosis.
No Regional Gray Matter Atrophy Differences between Pediatric- and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
B-57The Temporal Onset of Cognitive Fatigue in Multiple Sclerosis.
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Topical Application of Fingolimod Perturbs Cutaneous Inflammation.
Tocilizumab, MS, and NMOSD.
Sativex(®) in multiple sclerosis spasticity: a cost-effectiveness model.
Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter.
Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research.
Behavioral interventions in multiple sclerosis: a biopsychosocial perspective.
In vitro modeling of central nervous system myelination and remyelination.
[Cyclophosphamide pulse therapy effective for childhood-onset refractory multiple sclerosis: a case report].
Sodium accumulation is associated with disability and a progressive course in multiple sclerosis.
Safety, tolerability, and efficacy of orally administered cannabinoids in MS.
Flow cytometric analysis of cerebrospinal fluid samples and its usefulness in routine clinical practice.
Cytochrome P450 3A4 is the major enzyme responsible for the metabolism of laquinimod, a novel immunomodulator.
The Symptom Inventory Disability-Specific Short Forms for Multiple Sclerosis: Reliability and Factor Structure.

Pages